Citation
C. Moon et al., Use of docetaxel (Taxotere (R)) in patients with paclitaxel (Taxol (R)) hypersensitivity, ANTI-CANC D, 11(7), 2000, pp. 565-568
Citations number
15
Categorie Soggetti
Pharmacology,"Onconogenesis & Cancer Research
Journal title
ANTI-CANCER DRUGS
ISSN journal
09594973
→ ACNP
Volume
11
Issue
7
Year of publication
2000
Pages
565 - 568
Database
ISI
SICI code
0959-4973(200008)11:7<565:UOD((I>2.0.ZU;2-R
Abstract
Anaphylaxis or significant hypersensitivity reaction is one of the most cat
astrophic potential complications of chemotherapy. There is a 2-5% risk of
hypersensitivity with paclitaxel, a commonly used chemotherapeutic agent fo
r various cancers. Three patients, who developed hypersensitivity to paclit
axel infusion, received docetaxel without allergic reactions. Docetaxel may
therefore be an alternative treatment for patients with paclitaxel hyperse
nsitivity. [(C) 2000 Lippincott Williams & Wilkins].